P803: CRIP1 INDUCES PIS RESISTANCE BY FORMING A COMPLEX WITH USP7/PA200 AND ENHANCING PROTEASOME ACTIVITY AND AUTOPHAGY IN MULTIPLE MYELOMA

por Yu, Zhen, Tang, Peixia, Xu, Zhenshu, Qiu, Lugui, Hao, Mu
Publicado 2023

P818: DNP73 PROMOTES DRUG RESISTANCE AND IMMUNE EVASION IN MULTIPLE MYELOMA BY MODULATING MYC/CD47 AXIS

por Liu, Lanting, Xu, Jie, Gong, Lixin, Sun, Xiyue, Qiu, Lugui, Hao, Mu
Publicado 2023

Four and a Half LIM Domains Protein 2 Mediates Bortezomib-Induced Osteogenic Differentiation of Mesenchymal Stem Cells in Multiple Myeloma Through p53 Signaling and β-Catenin Nucle...

por Xie, Zhenqing, Xu, Yan, Wei, Xiaojing, An, Gang, Hao, Mu, Yu, Zhen, Qiu, Lugui
Publicado 2021

Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells

por Hao, Mu, Zhang, Li, An, Gang, Sui, Weiwei, Yu, Zhen, Zou, Dehui, Xu , Yan, Chang, Hong, Qiu, Lugui
Publicado 2011

MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma

por Li, Fei, Xu, Yan, Deng, Shuhui, Li, Zengjun, Zou, Dehui, Yi, Shuhua, Sui, Weiwei, Hao, Mu, Qiu, Lugui
Publicado 2015

P810: A NOVEL INDIRUBIN-3-MONOXIME DERIVATIVES FUNCTION AS DISRUPTORS OF PROTEOSTASIS VIA TARGETING TRIM28 IN MULTIPLE MYELOMA

por Fang, Teng, Sun, Hao, Sun, Xiyue, Gong, Lixin, Tang, Peixia, Yu, Zhen, Liu, Lanting, Xie, Shiyi, Hao, Mu, Qiu, Lugui
Publicado 2023

P838: EXOSOME MIRNAS PROFILING IN SERUM AND PROGNOSTIC EVALUATION IN PATIENTS WITH MULTIPLE MYELOMA

por Fang, Teng, Sun, Hao, Hao, Mu, Qiu, Lugui, Sun, Xiyue, Zhu, Guoqing, He, Yi, Gong, Lixin, Tang, Peixia, Yu, Zhen, Liu, Lanting, Xie, Shiyi
Publicado 2023

Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells

por Yang, Yuanyuan, Zhang, Xiaolong, Lin, Fangzhen, Xiong, Mengshang, Fan, Dongmei, Yuan, Xiangfei, Lu, Yang, Song, Yuewen, Zhang, Yizi, Hao, Mu, Ye, Zhou, Zhang, Yanjun, Wang, Jianxiang, Xiong, Dongsheng
Publicado 2019

Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma

por Lv, Junqiang, Sun, Hao, Gong, Lixin, Wei, Xiaojing, He, Yi, Yu, Zhen, Liu, Lanting, Yi, Shuhua, Sui, Weiwei, Xu, Yan, Deng, Shuhui, An, Gang, Yao, Zhi, Qiu, Lugui, Hao, Mu
Publicado 2022

Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma

por Li, Fei, Xu, Yan, Deng, Ping, Yang, Ye, Sui, Weiwei, Jin, Fengyan, Hao, Mu, Li, Zengjun, Zang, Meirong, Zhou, Dehui, Gu, Zhimin, Ru, Kun, Wang, Jianxiang, Cheng, Tao, Qiu, Lugui
Publicado 2015

A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer

por Lin, Fangzhen, Xiong, Mengshang, Hao, Wei, Song, Yuewen, Liu, Ruoqi, Yang, Yuanyuan, Yuan, Xiangfei, Fan, Dongmei, Zhang, Yizi, Hao, Mu, Ye, Zhou, Lu, Yang, Zhang, Yanjun, Wang, Jianxiang, Xiong, Dongsheng
Publicado 2021

Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia

por Sun, Hao, Fang, Teng, Wang, Tingyu, Yu, Zhen, Gong, Lixin, Wei, Xiaojing, Wang, Huijun, He, Yi, Liu, Lanting, Yan, Yuting, Sui, Weiwei, Xu, Yan, Yi, Shuhua, Qiu, Lugui, Hao, Mu
Publicado 2022

Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis

por Hao, Mu, Zang, Meirong, Zhao, Lei, Deng, Shuhui, Xu, Yan, Qi, Fang, An, Gang, Qin, Yu, Sui, Weiwei, Li, Fei, Yang, Wenjuan, Li, Zengjun, Yi, Shuhua, Zou, Dehui, Zhan, Fenghuang, Qiu, Lugui
Publicado 2016

Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment

por Wei, Xiaojing, Yu, Zhen, Tang, Peixia, Sun, Hao, Gong, Lixin, Liu, Lanting, Fang, Teng, He, Yi, Wang, Tingyu, Sui, Weiwei, Xu, Yan, An, Gang, Xu, Zhenshu, Ma, Xiaoke, Qiu, Lugui, Hao, Mu
Publicado 2023

Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma

por Fang, Teng, Sun, Hao, Sun, Xiyue, He, Yi, Tang, Peixia, Gong, Lixin, Yu, Zhen, Liu, Lanting, Xie, Shiyi, Wang, Tingyu, Xu, Zhenshu, Yi, Shuhua, An, Gang, Xu, Yan, Zhu, Guoqing, Qiu, Lugui, Hao, Mu
Publicado 2023

Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment

por Liu, Lanting, Yu, Zhen, Cheng, Hui, Mao, Xuehan, Sui, Weiwei, Deng, Shuhui, Wei, Xiaojing, Lv, Junqiang, Du, Chenxing, Xu, Jie, Huang, Wenyang, Xia, Shuang, An, Gang, Zhou, Wen, Ma, Xiaoke, Cheng, Tao, Qiu, Lugui, Hao, Mu
Publicado 2020

Detection of recurrent cytogenetic aberrations in multiple myeloma: A comparison between MLPA and iFISH

por Zang, Meirong, Zou, Dehui, Yu, Zhen, Li, Fei, Yi, Shuhua, Ai, Xiaofei, Qin, Xiaoqi, Feng, Xiaoyan, Zhou, Wen, Xu, Yan, Li, Zengjun, Hao, Mu, Sui, Weiwei, Deng, Shuhui, Acharya, Chirag, Zhao, Yaozhong, Ru, Kun, Qiu, Lugui, An, Gang
Publicado 2015

Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s

por Zang, Meirong, Guo, Jiaojiao, Liu, Lanting, Jin, Fengyan, Feng, Xiangling, An, Gang, Qin, Xiaoqi, Wu, Yangbowen, Lei, Qian, Meng, Bin, Zhu, Yinghong, Guan, Yongjun, Deng, Shuhui, Hao, Mu, Xu, Yan, Zou, Dehui, Wu, Minghua, Qiu, Lugui, Zhou, Wen
Publicado 2020

Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma

por Shi, Lihui, Qin, Xiaoqi, Wang, Huijun, Xia, Yonghui, Li, Yuanyuan, Chen, Xuejing, Shang, Lei, Tai, Yu-Tzu, Feng, Xiaoyan, Acharya, Prakrati, Acharya, Chirag, Xu, Yan, Deng, Shuhui, Hao, Mu, Zou, Dehui, Zhao, Yaozhong, Ru, Kun, Qiu, Lugui, An, Gang
Publicado 2016

Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma

por Yu, Zhen, Wei, Xiaojing, Liu, Lanting, Sun, Hao, Fang, Teng, Wang, Lu, Li, Ying, Sui, Weiwei, Wang, Kefei, He, Yi, Zhao, Yaozhong, Huang, Wenyang, An, Gang, Meng, Fancui, Huang, Changjiang, Yu, Tengteng, Anderson, Kenneth C., Cheng, Tao, Qiu, Lugui, Hao, Mu
Publicado 2022